ArticleBMC infectious diseases2026
Genetic diversity, antimicrobial resistance, and biofilm-associated virulence in clinical Enterococcus faecalis isolates from Hamedan, Iran.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnterococcus faecalis is a leading cause of hospital-acquired infections, exhibiting high-level antimicrobial resistance, robust biofilm-forming capacity, and diverse virulence traits. This study aimed to investigate the distribution patterns, antibiotic resistance profiles, biofilm formation ability, virulence gene presence, and genetic diversity of clinical E. faecalis isolates in Hamedan, Iran.
methodsSixty E. faecalis isolates were recovered from diverse clinical samples across three hospitals. Antimicrobial susceptibility was assessed by disk diffusion and MIC methods. Biofilm formation was quantified using the microtiter plate assay. The presence of the gelE gene and gelatinase activity was determined by PCR and phenotypic assays. Genetic relatedness was evaluated using ERIC-PCR.
resultsThe majority of isolates (96.67%) exhibited biofilm-forming ability, with 78.3% producing moderate to strong biofilms. Multidrug resistance was detected in 80% of isolates, including 56.7% vancomycin-resistant and 70% high-level gentamicin-resistant strains, with a gelE prevalence of 56.6%. A significant association was found between biofilm strength and both MDR (p < 0.001) and gelE presence (p = 0.0027). Gelatinase activity was confirmed in 82% of gelE-positive isolates. ERIC-PCR revealed high genetic diversity, with 50 unique types and seven clusters sharing ≥ 80% similarity. While some genetically similar isolates shared phenotypic traits, variability in biofilm production and gelE carriage was observed even among closely related strains.
conclusionsThe partial discordance between genotype and phenotype underscores the need for integrated molecular and phenotypic surveillance to inform infection control and antimicrobial stewardship strategies. Further studies using high-resolution genotyping are warranted to elucidate the mechanisms underlying strain dissemination and pathogenicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.